Finance

Lists
Outlook: 39.1% bullish·13.0% bearish
Go to analysis
ANGO:NASDAQ
AngioDynamics, Inc.
11,05 USD
+1,38%
(+0,15) 1D
10,79 USD
-2,37% (-0,26)
After hours
Closed: 14-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANGO...
Open
10,79 USD
High
11,48 USD
Low
10,73 USD
Mkt. cap
464,70 млн
Avg. vol.
744,34 миң
Volume
1,59 млн
52-wk high
16,29 USD
52-wk low
9,39 USD
EPS
-0,88 USD
Beta
0,30
Shares outstanding
42,05 млн
No. of employees
632
Open
10,79 USD
High
11,48 USD
Low
10,73 USD
Mkt. cap
464,70 млн
Avg. vol.
744,34 миң
Volume
1,59 млн
52-wk high
16,29 USD
52-wk low
9,39 USD
EPS
-0,88 USD
Beta
0,30
Shares outstanding
42,05 млн
No. of employees
632
News stories
From web sources and news partners
About AngioDynamics, Inc.
CEOJames Clemmer
Employees632
Founded1988-ж., 9-фев.
Headquarters-
SectorMedical device
Analyst ratings
Based on 2 analysts giving stock ratings to ANGO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANGO in the last 3 months.
Highest
Current 11,05 USD
20,00 USD (+81,00%)
Average
19,00 USD (+71,95%)
Lowest
18,00 USD (+62,90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
18,00 USD
+62,9%
10/14/2026
John Young CFA
Canaccord Genuity
Buy
Reiterated
20,00 USD
+81%
10/09/2026
Frank Takkinen
Lake Street
Buy
Maintained
24,00 USD
+117,2%
07/14/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
16,00 USD
+44,8%
04/06/2026
Last report
2026-ж., 8-окт.
Fiscal period
Q1 2027
-0,04 USD / -0,11 USD
+64,70%beat
Revenue / Est. (USD)
80,92 млн / 80,50 млн
+0,52%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. ноя.
2026-ж. фев.
2026-ж. май
2026-ж. авг.
Revenue
79,43 млн
78,42 млн
86,61 млн
80,92 млн
Cost of goods sold
34,65 млн
36,94 млн
39,83 млн
34,08 млн
Cost of revenue
34,65 млн
36,94 млн
39,83 млн
34,08 млн
Research and development expenses
7,63 млн
6,93 млн
8,03 млн
7,82 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,00 млн
38,31 млн
41,53 млн
42,61 млн
Operating expense
47,27 млн
47,91 млн
52,42 млн
53,16 млн
Total operating expenses
81,92 млн
84,85 млн
92,26 млн
87,24 млн
Operating income
-2,49 млн
-6,43 млн
-5,65 млн
-6,32 млн
Other non operating income
-128,00 миң
4,97 млн
-735,00 миң
94,00 миң
EBT including unusual items
-6,36 млн
-8,07 млн
-11,04 млн
-7,30 млн
EBT excluding unusual items
-2,72 млн
-1,55 млн
-6,49 млн
-6,32 млн
Income tax expense
-5,00 миң
12,00 миң
370,00 миң
-199,00 миң
Effective tax rate
0,08%
-0,15%
-3,35%
2,73%
Other operating expenses
-
-
138,00 миң
-
Net income
-6,35 млн
-8,08 млн
-11,40 млн
-7,10 млн
Net profit margin
-7,99%
-10,31%
-13,17%
-8,77%
Earnings per share
-
0,02
-0,07
-0,04
Interest and investment income
-
12,00 миң
1,00 миң
-
Interest expense
-102,00 миң
-100,00 миң
-106,00 миң
-88,00 миң
Net interest expenses
-102,00 миң
-88,00 миң
-105,00 миң
-88,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
3,26 млн
-838,00 миң
-353,00 миң
-823,00 миң
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору